{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:34:11Z","timestamp":1787240051568,"version":"build-2736575974"},"reference-count":161,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Drug resistance remains a significant challenge in cancer therapy, accounting for most relapses and contributing substantially to cancer-related mortality worldwide. Several molecular processes are linked to the development of resistance to anticancer drugs, with the most studied mechanisms including epigenetic changes, drug efflux, cell survival signalling pathways, and inactivation of anticancer drugs. Both intrinsic and acquired forms of resistance hinder tumour cell elimination, reducing treatment success. This translates to poorer patient outcomes and the need for more aggressive treatment regimens. Therefore, understanding these molecular processes is crucial for enhancing the efficacy of anticancer therapy. Medicinal plants offer potential to counter various resistance mechanisms through their diverse phytocompounds. These compounds may offer benefits including consistent availability, anticancer potency, few side effects, and minimal drug resistance. However, the bioavailability of these phytochemicals and the lack of extensive clinical trials remain key challenges. Therefore, this review provides in-depth information on the mechanisms that lead to drug resistance during cervical cancer therapy, the challenges related to phytochemical bioavailability, the current status, and future needs for clinical trials evaluating the application of medicinal plants to combat drug resistance in cancer cells.<\/jats:p>","DOI":"10.3390\/biology15020191","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T17:20:42Z","timestamp":1768929642000},"page":"191","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Medicinal Plants for Overcoming Drug Resistance in Cervical Cancer"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7572-8221","authenticated-orcid":false,"given":"Thabang Patience","family":"Marema","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Microbiology & Biotechnology, University of Limpopo, Private Bag X 1106, Sovenga 0727, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4778-5058","authenticated-orcid":false,"given":"Kagiso","family":"Laka","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Microbiology & Biotechnology, University of Limpopo, Private Bag X 1106, Sovenga 0727, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3179-8169","authenticated-orcid":false,"given":"Zukile","family":"Mbita","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Microbiology & Biotechnology, University of Limpopo, Private Bag X 1106, Sovenga 0727, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.3892\/ol.2020.11754","article-title":"Cervical Cancer in Low and Middle-income Countries (Review)","volume":"20","author":"Hull","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_2","first-page":"209","article-title":"Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","article-title":"Cervical cancer","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Sazonova, E.V., Yapryntseva, M.A., Pervushin, N.V., Tsvetcov, R.I., Zhivotovsky, B., and Kopeina, G.S. (2024). Cancer drug resistance: Targeting proliferation or programmed cell death. Cells, 13.","DOI":"10.3390\/cells13050388"},{"key":"ref_5","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10585-018-9903-0","article-title":"The challenge of drug resistance in cancer treatment: A current overview","volume":"35","author":"Nikolaou","year":"2018","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug Resistance in Cancer: An Overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancers"},{"key":"ref_9","first-page":"555600","article-title":"Chemotherapy Treatment and Strategy Schemes: A Review","volume":"2","author":"Alam","year":"2018","journal-title":"J. Toxicol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"100082","DOI":"10.1016\/j.medidd.2021.100082","article-title":"Recent advances in phytochemical-based Nano-formulation for drug-resistant Cancer","volume":"10","author":"More","year":"2021","journal-title":"Med. Drug Discov."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Tinoush, B., Shirdel, I., and Wink, M. (2020). Phytochemicals: Potential Lead Molecules for MDR Reversal. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00832"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Nishino, K., Yamasaki, S., Nakashima, R., Zwama, M., and Hayashi-Nishino, M. (2021). Function and inhibitory mechanisms of multidrug efflux pumps. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.737288"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"101821","DOI":"10.1016\/j.tranon.2023.101821","article-title":"Epigenetic modifications: Key players in cancer heterogeneity and drug resistance","volume":"39","author":"Sadida","year":"2024","journal-title":"Transl. Oncol."},{"key":"ref_14","first-page":"765","article-title":"Reactive oxygen species induced by Icaritin promote DNA strand breaks and apoptosis in human cervical cancer cells","volume":"41","author":"Chen","year":"2018","journal-title":"Oncol. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.20517\/cdr.2021.148","article-title":"DNA damage and metabolic mechanisms of cancer drug resistance","volume":"5","author":"Tiek","year":"2022","journal-title":"Cancer Drug Resist."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"102925","DOI":"10.1016\/j.bioorg.2019.102925","article-title":"Cisplatin: The first metal based Anticancer Drug","volume":"88","author":"Ghosh","year":"2019","journal-title":"Bioorg. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4062\/biomolther.2017.195","article-title":"Dysregulation of NRF2 in Cancer: From Molecular Mechanisms to Therapeutic Opportunities","volume":"26","author":"Jung","year":"2018","journal-title":"Biomol. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Bukowski, K., Kciuk, M., and Kontek, R. (2020). Mechanisms of multidrug resistance in cancer chemotherapy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093233"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: An evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Emran, T.B., Shahriar, A., Mahmud, A.R., Rahman, T., Abir, M.H., Siddiquee, M.F.R., Ahmed, H., Rahman, N., Nainu, F., and Wahyudin, E. (2022). Multidrug resistance in cancer: Understanding molecular mechanisms, immunoprevention and therapeutic approaches. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.891652"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12079-017-0435-1","article-title":"Tumour cell-intrinsic phenotypic plasticity facilitates adaptive cellular reprogramming driving acquired drug resistance","volume":"12","author":"Hammerlindl","year":"2017","journal-title":"J. Cell Commun. Signal."},{"key":"ref_22","first-page":"e1291","article-title":"Molecular and cellular paradigms of multidrug resistance in cancer","volume":"5","author":"Vaidya","year":"2020","journal-title":"Cancer Rep."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Weinberg, F., Ramnath, N., and Nagrath, D. (2019). Reactive oxygen species in the tumour microenvironment: An overview. Cancers, 11.","DOI":"10.3390\/cancers11081191"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.drup.2004.01.004","article-title":"Ros stress in cancer cells and therapeutic implications","volume":"7","author":"Pelicano","year":"2004","journal-title":"Drug Resist. Updat."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/bs.ircmb.2021.04.001","article-title":"Reactive oxygen species and DNA damage response in cancer","volume":"364","author":"Renaudin","year":"2021","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc1170","article-title":"Genomic instability\u2014The engine of tumorigenesis?","volume":"3","author":"Sieber","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_27","first-page":"3","article-title":"Mitochondrial electron transport chain, ROS generation and uncoupling (review)","volume":"44","author":"Zhao","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/s12276-020-00503-9","article-title":"Peroxisome quality control and dysregulated lipid metabolism in neurodegenerative diseases","volume":"52","author":"Jo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"198016","DOI":"10.1016\/j.virusres.2020.198016","article-title":"Human Papillomavirus-related Cancers and Mitochondria","volume":"286","year":"2020","journal-title":"Virus Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.3390\/ijms14023683","article-title":"NADPH Oxidase Biology and the Regulation of Tyrosine Kinase Receptor Signalling and Cancer Drug Cytotoxicity","volume":"14","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Dev, S.S., Abidin, S.A.Z., Farghadani, R., Othman, I., and Naidu, R. (2021). Receptor tyrosine kinases and their signalling pathways as therapeutic targets of curcumin in cancer. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.772510"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejphar.2018.09.031","article-title":"Targeting EphA4 abrogates intrinsic resistance to chemotherapy in well-differentiated cervical cancer cell line","volume":"84","author":"Kina","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.procbio.2020.09.032","article-title":"A paradoxical role of reactive oxygen species in cancer signalling pathway: Physiology and pathology","volume":"100","author":"Ramalingam","year":"2021","journal-title":"Process. Biochem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1089\/ars.2012.4529","article-title":"Reactive oxygen species in cancer stem cells","volume":"16","author":"Shi","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/ijgc-2020-001587","article-title":"Oxidative damage and antioxidants in cervical cancer","volume":"31","author":"Preci","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"Ros in cancer therapy: The bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1177271918755391","DOI":"10.1177\/1177271918755391","article-title":"Reactive oxygen species: A key constituent in cancer survival","volume":"13","author":"Kumari","year":"2018","journal-title":"Biomark. Insights"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"012051","DOI":"10.1088\/1755-1315\/713\/1\/012051","article-title":"Hsp70 (heat shock protein 70) expression and antioxidant as a protective against oxidative stress triggered by sub-maximal physical activity","volume":"713","author":"Harahap","year":"2021","journal-title":"IOP Conf. Ser. Earth Environ. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"111896","DOI":"10.1016\/j.exger.2022.111896","article-title":"Relationship between heat shock proteins and cellular resistance to drugs and ageing","volume":"167","year":"2022","journal-title":"Exp. Gerontol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Van Loenhout, J., Peeters, M., Bogaerts, A., Smits, E., and Deben, C. (2020). Oxidative Stress-Inducing Anticancer Therapies: Taking a Closer Look at Their Immunomodulating Effects. Antioxidants, 9.","DOI":"10.3390\/antiox9121188"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"13670","DOI":"10.1038\/s41598-024-64255-6","article-title":"PCK1-mediated glycogenolysis facilitates ROS clearance and chemotherapy resistance in cervical cancer stem cells","volume":"14","author":"Chen","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"102754","DOI":"10.1016\/j.redox.2023.102754","article-title":"Drug-induced oxidative stress in cancer treatments: Angel or devil?","volume":"63","author":"Jiang","year":"2023","journal-title":"Redox Biol."},{"key":"ref_43","first-page":"4","article-title":"Treating cervical cancer with herbs: A review","volume":"11","author":"Joseph","year":"2018","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"AL-Ishaq, R.K., Overy, A.J., and B\u00fcsselberg, D. (2020). Phytochemicals and Gastrointestinal Cancer: Cellular Mechanisms and Effects to Change Cancer Progression. Biomolecules, 10.","DOI":"10.3390\/biom10010105"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"690","DOI":"10.37349\/etat.2023.00161","article-title":"Anticancer action of naturally occurring emodin for the controlling of cervical cancer","volume":"4","author":"Lande","year":"2023","journal-title":"Explor. Target. Anti-Tumor Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"340778","DOI":"10.1016\/j.aca.2022.340778","article-title":"A highly selective red-emitting fluorescent probe and its micro-nano-assembly for imaging endogenous peroxynitrite (ONOO\u2212) in living cells","volume":"1241","author":"Zhang","year":"2023","journal-title":"Anal. Chim. Acta"},{"key":"ref_47","first-page":"430","article-title":"Phytochemical and pharmacological profile of Cassia tora Linn. An Overview","volume":"1","author":"Jain","year":"2010","journal-title":"Indian J. Nat. Prod. Resour."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"He, M., Xia, L., and Li, J. (2021). Potential Mechanisms of Plant-Derived Natural Products in the Treatment of Cervical Cancer. Biomolecules, 11.","DOI":"10.3390\/biom11101539"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"117415","DOI":"10.1016\/j.biopha.2024.117415","article-title":"Baicalein enhances cisplatin sensitivity in cervical cancer cells by promoting cuproptosis through the Akt pathway","volume":"179","author":"Jin","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13045-021-01053-x","article-title":"Novel therapies emerging in oncology to target the TGF-\u03b2 pathway","volume":"14","author":"Kim","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"a022277","DOI":"10.1101\/cshperspect.a022277","article-title":"TGF-\u03b2 Family Signalling in Tumour Suppression and Cancer Progression","volume":"9","author":"Seoane","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.cell.2015.01.043","article-title":"TGF-\u03b2 promotes heterogeneity and drug resistance in squamous cell carcinoma","volume":"160","author":"Oshimori","year":"2015","journal-title":"Cell"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1517\/13543784.2011.546344","article-title":"Mechanisms of drug resistance in kinases","volume":"20","author":"Sauer","year":"2011","journal-title":"Expert Opin. Investig. Drugs."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Bou Antoun, N., and Chioni, A.M. (2023). Dysregulated Signalling Pathways Driving Anticancer Drug Resistance. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202307.1284.v1"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12943-015-0361-x","article-title":"The role of the PI3K\/Akt\/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses","volume":"14","author":"Zhang","year":"2015","journal-title":"Mol. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"235","DOI":"10.32604\/or.2022.025323","article-title":"PI3K\/AKT signalling pathway as a critical regulator of Cisplatin response in tumour cells","volume":"29","author":"Navaei","year":"2022","journal-title":"Oncol. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/cells12040659","article-title":"Doxorubicin\u2014An Agent with Multiple Mechanisms of Anticancer Activity","volume":"12","author":"Kciuk","year":"2023","journal-title":"Cells"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Rascio, F., Spadaccino, F., Rocchetti, M.T., Castellano, G., Stallone, G., Netti, G.S., and Ranieri, E. (2021). The Pathogenic Role of PI3K\/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review. Cancers, 13.","DOI":"10.3390\/cancers13163949"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.omto.2019.05.005","article-title":"FoxM1 Induced Paclitaxel Resistance via Activation of the FoxM1\/PHB1\/RAF-MEK-ERK Pathway and Enhancement of the ABCA2 Transporter","volume":"14","author":"Huang","year":"2019","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Yang, C., Mai, Z., Liu, C., Yin, S., Cai, Y., and Xia, C. (2022). Natural Products in Preventing Tumour Drug Resistance and Related Signalling Pathways. Molecules, 27.","DOI":"10.3390\/molecules27113513"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"152556","DOI":"10.1016\/j.prp.2019.152556","article-title":"Curcumin inhibits NF-kB and Wnt\/\u03b2-catenin pathways in cervical cancer cells","volume":"215","author":"Ghasemi","year":"2019","journal-title":"Pathol. Res. Pract."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"7627","DOI":"10.1080\/07391102.2022.2123390","article-title":"Flavonoids as P-glycoprotein inhibitors for multidrug resistance in cancer: An in-silico approach","volume":"41","author":"Kumar","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_63","first-page":"9537","article-title":"Dioscin suppresses the viability of ovarian cancer cells by regulating the VEGFR2 and PI3K\/AKT\/MAPK signalling pathways","volume":"15","author":"Guo","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00432-023-05572-7","article-title":"Natural products targeting the MAPK-signalling pathway in cancer: Overview","volume":"150","author":"Shi","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Chen, G., Yang, Z., Wen, D., Li, P., Xiong, Q., and Wu, C. (2023). Oridonin Inhibits Mycobacterium marinum Infection-Induced Oxidative Stress In Vitro and In Vivo. Pathogens, 12.","DOI":"10.3390\/pathogens12060799"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12272-021-01321-x","article-title":"The role of epithelial\u2013mesenchymal transition-regulating transcription factors in anti-cancer drug resistance","volume":"44","author":"Seo","year":"2021","journal-title":"Arch. Pharm. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","article-title":"The molecular mechanisms and therapeutic strategies of EMT in tumour progression and metastasis","volume":"15","author":"Huang","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1038\/cddis.2011.61","article-title":"Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters","volume":"2","author":"Saxena","year":"2011","journal-title":"Cell Death Dis."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Du, B., and Shim, J. (2016). Targeting Epithelial\u2013Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer. Molecules, 21.","DOI":"10.3390\/molecules21070965"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s00204-021-03063-7","article-title":"Cancer drug resistance induced by EMT: Novel therapeutic strategies","volume":"95","author":"Brozovic","year":"2021","journal-title":"Arch. Toxicol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"82","DOI":"10.21037\/jtd.2019.06.11","article-title":"Epithelial-to-mesenchymal transition and drug resistance: Transitioning away from death","volume":"11","author":"Song","year":"2019","journal-title":"J. Thorac. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"15287","DOI":"10.1038\/s41598-024-64781-3","article-title":"Bergenin inhibits growth of human cervical cancer cells by decreasing Galectin-3 and MMP-9 expression","volume":"14","author":"Chauhan","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_74","first-page":"298","article-title":"Curcumin: Reclaiming the lost ground against cancer resistance","volume":"4","author":"Shaikh","year":"2021","journal-title":"Cancer Drug Resist."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Nunzio, A.C., Cuciniello, R., Gianluigi, D.P., Piccioni, M., Filosa, S., and Crispi, S. (2023). An Overview of the Enhanced Effects of Curcumin and Chemotherapeutic Agents in Combined Cancer Treatments. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612587"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.2174\/0929867327666200228110738","article-title":"The \u2018Big Five\u2019 Phytochemicals Targeting Cancer Stem Cells: Curcumin, EGCG, Sulforaphane, Resveratrol and Genistein","volume":"28","author":"Naujokat","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of Cancer Drug Resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nrc3819","article-title":"Poised epigenetic states and acquired drug resistance in cancer","volume":"14","author":"Brown","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13045-019-0818-2","article-title":"Emerging insights of tumour heterogeneity and drug resistance mechanisms in lung cancer targeted therapy","volume":"12","author":"Lim","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Lumpp, T., St\u00f6\u00dfer, S., Fischer, F., Hartwig, A., and K\u00f6berle, B. (2024). Role of Epigenetics for the Efficacy of Cisplatin. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25021130"},{"key":"ref_81","first-page":"8260652","article-title":"The Progress of Methylation Regulation in Gene Expression of Cervical Cancer","volume":"2011","author":"Feng","year":"2018","journal-title":"Int. J. Genom."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Zhu, H., Zhu, H., Tian, M., Wang, D., He, J., and Xu, T. (2020). DNA Methylation and Hydroxymethylation in Cervical Cancer: Diagnosis, Prognosis and Treatment. Front. Genet., 11.","DOI":"10.3389\/fgene.2020.00347"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3892\/br.2021.1436","article-title":"The role of HPV-induced epigenetic changes in cervical carcinogenesis (Review)","volume":"15","author":"Allyrio","year":"2021","journal-title":"Biomed. Rep."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3892\/etm.2021.10916","article-title":"Epigenetic approaches for cervical neoplasia screening (Review)","volume":"22","author":"Albulescu","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1038\/s41598-022-09980-6","article-title":"TLR4 and SARM1 modulate survival and chemoresistance in an HPV-positive cervical cancer cell line","volume":"12","author":"Morale","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1010428317710586","DOI":"10.1177\/1010428317710586","article-title":"Toll-like receptor 4 promotes proliferation and apoptosis resistance in human papillomavirus\u2013related cervical cancer cells through the Toll-like receptor 4\/nuclear factor-\u03baB pathway","volume":"39","author":"Jiang","year":"2017","journal-title":"Tumor Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12935-015-0248-3","article-title":"Changes in DNA methylation are associated with the development of drug resistance in cervical cancer cells","volume":"15","author":"Chen","year":"2015","journal-title":"Cancer Cell Int."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1476-4598-4-38","article-title":"Epigenetics of cervical cancer. An overview and therapeutic perspectives","volume":"4","author":"Lizano","year":"2005","journal-title":"Mol. Cancer"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5487\/TR.2017.33.1.001","article-title":"Oxidative Stress, Nrf2, and Epigenetic Modification Contribute to Anticancer Drug Resistance","volume":"33","author":"Kang","year":"2017","journal-title":"Toxicol. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.semcancer.2020.12.022","article-title":"Targeting epigenetic regulatory machinery to overcome cancer therapy resistance","volume":"83","author":"Guo","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e1183","DOI":"10.1038\/cddis.2014.149","article-title":"Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: Involvement of TET-dependent DNA demethylation","volume":"5","author":"Kang","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Jeong, H.M., Kwon, M.J., and Shin, Y.K. (2014). Overexpression of Cancer-Associated Genes via Epigenetic Derepression Mechanisms in Gynecologic Cancer. Front. Oncol., 4.","DOI":"10.3389\/fonc.2014.00012"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Greenberg, D., and Soreq, H. (2013). Alternative Splicing. Brenner\u2019s Encyclopedia of Genetics, Elsevier Inc.","DOI":"10.1016\/B978-0-12-374984-0.00043-7"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13045-016-0315-9","article-title":"Aberrant splicing and drug resistance in AML","volume":"9","author":"Shouse","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Hughes, P., Bouillet, P., and Strasser, A. (2005). Role of Bim and other Bcl-2 Family Members in Autoimmune and Degenerative Diseases. Current Directions in Autoimmunity, Karger Publisher.","DOI":"10.1159\/000090773"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00266-015-0566-9","article-title":"Traditional Chinese Medicine: Salvia miltiorrhiza Enhances Survival Rate of Autologous Adipose Tissue Transplantation in Rabbit Model","volume":"39","author":"Yu","year":"2015","journal-title":"Aesthetic Plast. Surg."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13148-023-01481-1","article-title":"Epigenetic effects of herbal medicine","volume":"15","author":"Wu","year":"2023","journal-title":"Clin. Epigenet."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s10616-018-0251-3","article-title":"Rhaponticum carthamoides transformed root extract inhibits human glioma cells viability, induces double strand DNA damage, H2A.X phosphorylation, and PARP1 cleavage","volume":"70","author":"Toma","year":"2018","journal-title":"Cytotechnology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12935-023-03161-9","article-title":"Epigallocatechin-3-gallate and its nanoformulation in cervical cancer therapy: The role of genes, MicroRNA and DNA methylation patterns","volume":"23","author":"Wang","year":"2023","journal-title":"Cancer Cell Int."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Carlos-Reyes, \u00c1., L\u00f3pez-Gonz\u00e1lez, J.S., Meneses-Flores, M., Gallardo-Rinc\u00f3n, D., Ru\u00edz-Garc\u00eda, E., Marchat, L.A., la Vega, H.A.-D., de la Cruz, O.N.H., and L\u00f3pez-Camarillo, C. (2019). Dietary Compounds as Epigenetic Modulating Agents in Cancer. Front. Genet., 10.","DOI":"10.3389\/fgene.2019.00079"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Pal, A., and Kundu, R. (2020). Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.03116"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/mc.20170","article-title":"Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis","volume":"45","author":"Divya","year":"2006","journal-title":"Mol. Carcinog."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.canlet.2014.09.037","article-title":"Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer","volume":"356","author":"Munagala","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3892\/ijo.2023.5567","article-title":"Mechanism of multidrug resistance to chemotherapy mediated by P-glycoprotein (Review)","volume":"63","author":"Tian","year":"2023","journal-title":"Int. J. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/138161282005140214165212","article-title":"ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development","volume":"20","author":"Choi","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"145000","DOI":"10.1016\/j.gene.2020.145000","article-title":"Rucaparib antagonize multidrug resistance in cervical cancer cells through blocking the function of ABC transporters","volume":"759","author":"Chen","year":"2020","journal-title":"Gene"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Dong, X.-D., Zhang, M., Cai, C.-Y., Teng, Q.-X., Wang, J.-Q., Fu, Y.-G., Cui, Q., Patel, K., Wang, D.-T., and Chen, Z.-S. (2022). Overexpression of ABCB1 associated with the resistance to the kras-G12C specific inhibitor ARS-1620 in cancer cells. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.843829"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2147\/DDDT.S106412","article-title":"Molecular mechanisms of cisplatin resistance in cervical cancer","volume":"10","author":"Zhu","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0026-895X(24)23190-4","article-title":"Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells","volume":"55","author":"Cui","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"ref_110","first-page":"5162","article-title":"Curcumin reverses doxorubicin resistance via inhibition the efflux function of ABCB4 in doxorubicin-resistant breast cancer cells","volume":"19","author":"Wen","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.lfs.2005.12.003","article-title":"Flavonoid\u2013drug interactions: Effects of flavonoids on ABC transporters","volume":"78","author":"Morris","year":"2006","journal-title":"Life Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1139\/o05-140","article-title":"Epigenetic silencing of the MGMT gene in cancer","volume":"83","author":"Soejima","year":"2005","journal-title":"Biochem. Cell Biol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Stucci, L.S., Intern\u00f2, V., Tucci, M., Perrone, M., Mannavola, F., Palmirotta, R., and Porta, C. (2021). The ATM gene in breast cancer: Its relevance in clinical practice. Genes, 12.","DOI":"10.3390\/genes12050727"},{"key":"ref_114","unstructured":"Rodrigues, A.S., Gomes, B.C., Martins, C., Gromicho, M., Oliveira, N.G., Guerreiro, P.S., and Rueff, J. (2013). DNA Repair and Resistance to Cancer Therapy. New Research Directions in DNA Repair, OpenIntech."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/em.22087","article-title":"Mechanisms of DNA damage, repair, and mutagenesis","volume":"58","author":"Chatterjee","year":"2017","journal-title":"Environ. Mol. Mutagen."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Mahapatra, E., Das, S., Biswas, S., Ghosh, A., Sengupta, D., Roy, M., and Mukherjee, S. (2021). Insights of Cisplatin Resistance in Cervical Cancer: A Decision Making for Cellular Survival. Cervical Cancer\u2014A Global Public Health Treatise, IntechOpen.","DOI":"10.5772\/intechopen.98489"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Nguyen, V.T., Winterman, S., Playe, M., Benbara, A., Zelek, L., Pamoukdjian, F., and Bousquet, G. (2022). Dose-intense cisplatin-based neoadjuvant chemotherapy increases survival in advanced cervical cancer: An up-to-date meta-analysis. Cancers, 14.","DOI":"10.3390\/cancers14030842"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Li, L.Y., Guan, Y., Chen, X.S., Yang, J.M., and Cheng, Y. (2020). DNA Repair Pathways in Cancer Therapy and Resistance. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.629266"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3390\/molecules13081551","article-title":"5-Fluorouracil: Mechanisms of Resistance and Reversal Strategies","volume":"13","author":"Zhang","year":"2008","journal-title":"Molecules"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/bjc.2011.498","article-title":"Topoisomerase I inhibition in colorectal cancer: Biomarkers and therapeutic targets","volume":"106","author":"Gilbert","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Lagunas-Rangel, F.A., and Berm\u00fadez-Cruz, R.M. (2020). Natural Compounds That Target DNA Repair Pathways and Their Therapeutic Potential to Counteract Cancer Cells. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.598174"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jphs.2015.11.001","article-title":"Resveratrol, a potential radiation sensitizer for glioma stem cells both in vitro and in vivo","volume":"129","author":"Wang","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.critrevonc.2007.02.001","article-title":"Mechanisms of resistance to Cisplatin and Carboplatin","volume":"63","author":"Stewart","year":"2007","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Chai, J.Y., Sugumar, V., Alshanon, A.F., Wong, W.F., Fung, S.Y., and Looi, C.Y. (2021). Defining the role of GLI\/hedgehog signalling in chemoresistance: Implications in therapeutic approaches. Cancers, 13.","DOI":"10.3390\/cancers13194746"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Zahreddine, H., and Borden, K.L.B. (2013). Mechanisms and insights into drug resistance in cancer. Front. Pharmacol., 4.","DOI":"10.3389\/fphar.2013.00028"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1124\/dmd.122.001131","article-title":"Activation\/Inactivation of Anticancer Drugs by CYP3A4: Influencing Factors for Personalized Cancer Therapy","volume":"51","author":"Wang","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"ref_128","first-page":"9","article-title":"Phytochemicals Modify the Action of Cancer Cells Mitochondrial Drug-Resistance Mechanism","volume":"2","author":"Das","year":"2023","journal-title":"Sci. Pharm."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Zou, J.-Y., Chen, Q.-L., Luo, X.-C., Damdinjav, D., Abdelmohsen, U.R., Li, H.-Y., Battulga, T., Chen, H.-B., Wang, Y.-Q., and Zhang, J.-Y. (2024). Natural products reverse cancer multidrug resistance. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1348076"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1017\/S0029665107005459","article-title":"Phytochemicals and cancer","volume":"66","author":"Johnson","year":"2007","journal-title":"Proc. Nutr. Soc."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1745-7254.2007.00694.x","article-title":"Cancer chemoprevention by phytochemicals: Potential molecular targets, biomarkers and animal models","volume":"28","author":"Kwon","year":"2007","journal-title":"Acta Pharm. Sin."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11101-013-9327-z","article-title":"Overcoming chemotherapy resistance with herbal medicines: Past, present and future perspectives","volume":"13","author":"Wang","year":"2013","journal-title":"Phytochem. Rev."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jep.2018.04.036","article-title":"Cytotoxicity of 18 Cameroonian medicinal plants against drug sensitive and multi-factorial drug resistant cancer cells","volume":"222","author":"Mbaveng","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Hull, R., Mabeta, P., Chauke-Malinga, N., Molefi, T., Chatziioannou, A., and Dlamini, Z. (2024). Reversal of resistance mechanisms in cervical cancer. Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer, Elsevier.","DOI":"10.1016\/B978-0-443-28985-9.00001-X"},{"key":"ref_135","first-page":"1","article-title":"Medicinal plants: Past history and future perspective","volume":"7","author":"Lorigooini","year":"2018","journal-title":"J. Herbmed Pharmacol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jep.2015.10.026","article-title":"Quantitative genotoxicity assays for analysis of medicinal plants: A systematic review","volume":"178","author":"Sponchiado","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"604152","DOI":"10.1155\/2014\/604152","article-title":"Medicinal plants and other living organisms with antitumour potential against lung cancer","volume":"2014","author":"Monteiro","year":"2014","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.7150\/jca.34374","article-title":"The Power of Phytochemicals Combination in Cancer Chemoprevention","volume":"11","author":"Rizeq","year":"2020","journal-title":"J. Cancer"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/1574892809666140619154838","article-title":"Combination of Phytochemicals as Adjuvants for Cancer Therapy","volume":"9","author":"Ho","year":"2014","journal-title":"Recent Pat. Anticancer. Drug Discov."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1189034","DOI":"10.1155\/2022\/1189034","article-title":"Underlying Anticancer Mechanisms and Synergistic Combinations of Phytochemicals with Cancer Chemotherapeutics: Potential Benefits and Risks","volume":"2022","author":"Ayaz","year":"2022","journal-title":"J. Food Qual."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Lino, J., Nyamai, D.W., and Njeru, S.N. (2024). Phytochemical analysis, in-vitro and in-silico study of antiproliferative activity of ethyl acetate fraction of Launaea cornuta (Hochst. ex Oliv. & Hiern) C. Jeffrey against human cervical cancer cell line. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1399885"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S2221-1691(13)60060-X","article-title":"Bioavailability enhancers of herbal origin: An overview","volume":"3","author":"Kesarwani","year":"2013","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2125.2012.04425.x","article-title":"Bioavailability of bioactive food compounds: A challenging journey to bioefficacy","volume":"75","author":"Rein","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2013.02.032","article-title":"Bioavailability of phytochemicals and its enhancement by drug delivery systems","volume":"334","author":"Aqil","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Funk, J.L., and Schneider, C. (2021). Perspective on Improving the Relevance, Rigor, and Reproducibility of Botanical Clinical Trials: Lessons Learned From Turmeric Trials. Front. Nutr., 8.","DOI":"10.3389\/fnut.2021.782912"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"8","DOI":"10.11604\/pamj-oh.2024.15.8.45309","article-title":"Regulation and practice of clinical trials of herbal medicines in French-speaking West African countries (WAEMU): Current status and challenges","volume":"15","author":"Sangho","year":"2024","journal-title":"PAMJ One Health"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4103\/0975-7406.168035","article-title":"Challenges and guidelines for clinical trial of herbal drugs","volume":"7","author":"Parveen","year":"2015","journal-title":"J. Pharm. Bioallied. Sci."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Liu, S., Liu, J., He, L., Liu, L., Cheng, B., Zhou, F., Cao, D., and He, Y. (2022). A Comprehensive Review on the Benefits and Problems of Curcumin with Respect to Human Health. Molecules, 27.","DOI":"10.3390\/molecules27144400"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Panossian, A. (2023). Challenges in phytotherapy research. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1199516"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Rudzi\u0144ska, A., Juchaniuk, P., Oberda, J., Wi\u015bniewska, J., Wojdan, W., Szklener, K., and Ma\u0144dziuk, S. (2023). Phytochemicals in Cancer Treatment and Cancer Prevention\u2014Review on Epidemiological Data and Clinical Trials. Nutrients, 15.","DOI":"10.3390\/nu15081896"},{"key":"ref_151","first-page":"326","article-title":"Investigating the Pharmacokinetics of Natural Products: Challenges and Advances in Bioavailability","volume":"10","author":"Asano","year":"2024","journal-title":"J. Pharmacogn. Nat. Prod."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.drudis.2009.05.009","article-title":"Traditional medicine-inspired approaches to drug discovery: Can Ayurveda show the way forward?","volume":"14","author":"Patwardhan","year":"2009","journal-title":"Drug Discov. Today"},{"key":"ref_153","unstructured":"ClinicalTrials.gov (2026, January 12). Curcumin Adjunct to Chemoradiotherapy in Cervical Cancer, Available online: https:\/\/clinicaltrials.gov\/study\/NCT06080841."},{"key":"ref_154","unstructured":"ClinicalTrials.gov (2026, January 12). Curcumin Vaginal Capsule for Cervical Intraepithelial Neoplasia, Available online: https:\/\/clinicaltrials.gov\/study\/NCT02554344."},{"key":"ref_155","unstructured":"ClinicalTrials.gov (2026, January 12). Curcumin in Advanced Pancreatic Cancer, Available online: https:\/\/clinicaltrials.gov\/study\/NCT00192842."},{"key":"ref_156","unstructured":"ClinicalTrials.gov (2026, January 12). Curcumin in Breast Cancer Patients, Available online: https:\/\/clinicaltrials.gov\/study\/NCT01740323."},{"key":"ref_157","unstructured":"ClinicalTrials.gov (2026, January 12). Green Tea Extract in Prostate Cancer Prevention, Available online: https:\/\/clinicaltrials.gov\/study\/NCT00596011."},{"key":"ref_158","unstructured":"ClinicalTrials.gov (2026, January 12). Resveratrol in Colon Cancer Prevention, Available online: https:\/\/clinicaltrials.gov\/study\/NCT00256334."},{"key":"ref_159","unstructured":"ClinicalTrials.gov (2026, January 12). Diindolylmethane in Breast Cancer Prevention, Available online: https:\/\/clinicaltrials.gov\/study\/NCT01391689."},{"key":"ref_160","unstructured":"ClinicalTrials.gov (2026, January 12). Indole-3-Carbinol in Cervical Intraepithelial Neoplasia, Available online: https:\/\/clinicaltrials.gov\/study\/NCT00988845."},{"key":"ref_161","unstructured":"ClinicalTrials.gov (2026, January 12). Active Hexose Correlated Compound (AHCC) for HPV Clearance, Available online: https:\/\/clinicaltrials.gov\/study\/NCT02405533."}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/15\/2\/191\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T05:18:22Z","timestamp":1769059102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/15\/2\/191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":161,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["biology15020191"],"URL":"https:\/\/doi.org\/10.3390\/biology15020191","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]}}}